AMGN
AMGEN INC
Biological Products, (No Diagnostic Substances)NasdaqLarge accelerated filer
Total Trades
26
Buys
0
Sells
21
Largest Trade
$1M+
Insiders
10
Activist Filings
8
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Santos Esteban | EVP, Operations | SELL | $1M+ | 55K | $379.12 | Mar 3, 2026 |
| Santos Esteban | EVP, Operations | EXERCISE | $1M+ | 55K | $169.19 | Mar 3, 2026 |
| Busch Matthew C. | VP, Finance & CAO | SELL | $100K–$500K | 1K | $375.79 | Feb 21, 2026 |
| Grygiel Nancy A. | SVP & CCO | SELL | $1M+ | 3K | $337.26 | Nov 22, 2025 |
| Grygiel Nancy A. | SVP & CCO | EXERCISE | $500K+ | 3K | $169.70 | Nov 22, 2025 |
| Khosla Rachna | SVP | SELL | $100K–$500K | 890 | $336.24 | Nov 14, 2025 |
| Gordon Murdo | EVP | SELL | $1M+ | 7K | $336.83 | Nov 14, 2025 |
| Grygiel Nancy A. | SVP & CCO | SELL | $100K–$500K | 1K | $296.99 | Aug 22, 2025 |
| Khosla Rachna | SVP | SELL | $100K–$500K | 2K | $289.68 | Jun 6, 2025 |
| Busch Matthew C. | VP, Finance & CAO | SELL | $100K–$500K | 1K | $279.69 | May 7, 2025 |
| Santos Esteban | EVP, Operations | SELL | $1M+ | 9K | $292.84 | Feb 22, 2025 |
| Santos Esteban | EVP, Operations | EXERCISE | $1M+ | 9K | $156.35 | Feb 22, 2025 |
| REESE DAVID M | CTO | SELL | $1M+ | 34K | $301.56 | Feb 22, 2025 |
| REESE DAVID M | CTO | EXERCISE | $1M+ | 9K | $156.35 | Feb 22, 2025 |
| Miller Derek | SVP, Human Resources | EXERCISE | $100K–$500K | 2K | $156.35 | Feb 21, 2025 |
| Miller Derek | SVP, Human Resources | SELL | $500K+ | 2K | $293.45 | Feb 21, 2025 |
| Grygiel Nancy A. | SVP & CCO | SELL | $500K+ | 2K | $313.09 | May 3, 2024 |
| Grygiel Nancy A. | SVP & CCO | SELL | $500K+ | 2K | $273.03 | Dec 5, 2023 |
| Graham Jonathan P | EVP | SELL | $1M+ | 10K | $272.81 | Nov 14, 2023 |
| Gordon Murdo | EVP | SELL | $1M+ | 10K | $262.43 | Aug 11, 2023 |
| Khosla Rachna | SVP | SELL | $100K–$500K | 387 | $292.90 | Nov 11, 2022 |
| Grygiel Nancy A. | SVP & CCO | SELL | $100K–$500K | 545 | $293.54 | Nov 8, 2022 |
| Williams R Sanders | Director | SELL | $15K–$50K | 200 | $249.96 | Aug 23, 2022 |
| ECKERT ROBERT | Director | SELL | $1M+ | 7K | $249.00 | Aug 19, 2022 |
| Williams R Sanders | Director | SELL | $100K–$500K | 600 | $250.00 | May 24, 2022 |
| Graham Jonathan P | EVP | SELL | $1M+ | 14K | $241.81 | May 10, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Sep 8, 2025
10.0%
53.9M shares
SC 13G/A · Apr 17, 2025
7.6%
40.8M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
9.2%
49.0M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 30, 2024
5.5%
0 shares
SC 13G/A · Jan 25, 2024
8.9%
47.8M shares
Capital Research Global Investors 95-1411037
SC 13G/A · Feb 11, 2022
3.9%
22.2M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Feb 10, 2022
5.4%
0 shares
SC 13G/A · Jan 31, 2022
8.9%
50.0M shares